Loading insider details...
Latest Form 4 (Aug 18, 2026): Purchase of 4,200 VRCA shares, $20.6K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 18, 2026 | Verrica Pharmaceuticals Inc. (VRCA) | Purchase | 4,200 | $20.6K |
| Jun 9, 2026 | Verrica Pharmaceuticals Inc. (VRCA) | Grant/Award | 233,840 | n/a |
| Nov 26, 2025 | Verrica Pharmaceuticals Inc. (VRCA) | Purchase | 2,357 | $10.0K |
| Mar 26, 2025 | Verrica Pharmaceuticals Inc. (VRCA) | Grant/Award | 325,000 | n/a |
| Aug 17, 2021 | Travere Therapeutics, Inc. (TVTX) | Grant/Award | 4,500 | n/a |
| Jul 29, 2021 | Travere Therapeutics, Inc. (TVTX) | Sale | 1,250 | $17.3K |
| May 13, 2021 | Travere Therapeutics, Inc. (TVTX) | Sale | 375 | $7.2K |
| Feb 9, 2021 | Travere Therapeutics, Inc. (TVTX) | Sale | 1,125 | $35.3K |
| Feb 5, 2021 | Travere Therapeutics, Inc. (TVTX) | Grant/Award | 4,500 | n/a |
| Feb 4, 2021 | Travere Therapeutics, Inc. (TVTX) | Sale | 1,250 | $36.1K |